GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible ...
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access manufacturer-sponsored savings at the pharmacy. Discounts will help reduce the ...
Open enrollment is your chance to review coverage, compare plans and save. Here’s how to make smart choices for 2026.
Shares for Santa Monica-based GoodRx climbed by 37% after announcing a deal to offer significantly discounted Wegovy and Ozempic to self-paying customers. GoodRx helps consumers locate discounted ...
Entering into a direct agreement with GoodRx does not waive a pharmacy's right to participate in ongoing litigation against GoodRx, the company added. WHAT'S THE IMPACT When a direct contract is ...
In June, GoodRx will provide a cost-plus model offering to independent community pharmacies through direct contracts, the company said May 22. Dubbed GoodRx Community Link, it will allow locally owned ...
GoodRx connects uninsured and underinsured consumers with prescription discounts, acting as a broker between consumers, PBMs, and pharmacies. Recent OBBBA legislation will significantly cut Medicaid ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in ...
GoodRx offers compelling value after a ~50% stock decline over the past 12 months, trading at just 6.1x FY25 adjusted EBITDA despite recent execution challenges. A new Novo Nordisk partnership for ...
GoodRx will pay $25 million to settle claims it shared users’ sensitive data with third parties like Meta and Google without consent. FTC found violations of federal law, including the Health Breach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results